ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,615, issued on June 30, was assigned to AnserBio Ltd (Nesher, Israel).
"Native cell derived vesicles containing tumor suppressor proteins for therapy" was invented by Alexander Tendler (Haifa, Israel) and Lana Volokh (Haifa, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of obtaining cell derived vesicles comprising an active wild-type p53 is disclosed. The method comprising: (i) isolating cell derived vesicles from a biological sample comprising cells; and (ii) treating the cell derived vesicles with a DNA damaging agent, or the method comprising: (i) treating cells with a DNA damaging agent; and (ii) isolating cell derived vesicles...